Arrowhead Research
ARWR
100 hedge funds and large institutions have $259M invested in Arrowhead Research in 2014 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 28 increasing their positions, 30 reducing their positions, and 36 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
7% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 30
9% less funds holding
Funds holding: 110 → 100 (-10)
22% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 36
43% less call options, than puts
Call options by funds: $3.49M | Put options by funds: $6.13M
52% less capital invested
Capital invested by funds: $541M → $259M (-$281M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OppenheimerFunds
New York
|
+$20.4M |
| 2 |
JP Morgan Chase
New York
|
+$16.4M |
| 3 |
BM
Bridger Management
New York
|
+$16M |
| 4 |
QF
QVT Financial
New York
|
+$13M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$7.67M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$76.5M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$21.1M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$20.2M |
| 4 |
PA
Perceptive Advisors
New York
|
-$18.4M |
| 5 |
VAM
Visium Asset Management
New York
|
-$15.4M |
ARWR Hedge Fund Activity: Q4 2014 in Review
100 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Arrowhead Research (ARWR) for Q4 2014, worth a combined $259M — down 52% from $541M a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of ARWR and 28 opened new positions — a net loss of 8 holders — while 30 trimmed existing stakes and 28 added.
The largest buyer was OppenheimerFunds, opening a new position worth an estimated $20.4M. The largest seller was OrbiMed, exiting entirely with an estimated $76.5M sold.
- 100 institutional investors held Arrowhead Research (ARWR) as of Q4 2014, down from 110 in Q3 2014.
- Funds reported $259M of Arrowhead Research stock for Q4 2014, down 52% quarter-over-quarter.
- 28 funds opened new Arrowhead Research positions in Q4 2014 and 36 closed out, a net change of -8 holders.
- The largest Arrowhead Research buyer in Q4 2014 was OppenheimerFunds, an estimated $20.4M added.
- The largest Arrowhead Research seller in Q4 2014 was OrbiMed, an estimated $76.5M sold.
Based on aggregated 13F filings for Q4 2014.